Orbifloxacin
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | veterinary use only |
Routes | Oral |
Identifiers | |
CAS number | 113617-63-3 |
ATCvet code | QJ01MA95 |
PubChem | CID 60605 |
ChemSpider | 54631 |
UNII | 660932TPY6 |
KEGG | D08299 |
ChEMBL | CHEMBL295433 |
Chemical data | |
Formula | C19H20F3N3O3 |
Mol. mass | 395.37 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1] marketed by Schering-Plough Animal Health.
See also
References
- ↑ Product Abstract - NADA 141-081. Retrieved on June 23, 2008.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.